Andrew Cittadine - Chief Operating Officer at Monopar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Issuer Symbol
MNPR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Cittadine since 09 Mar 2025

Holdings reported by Andrew Cittadine for Monopar Therapeutics

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 50,726 $3,312,407 $65.30 31 Dec 2025 Direct
Restricted Stock Units 52,593 $1,136,410 $22.00 02 Dec 2025 Direct Common Stock
Restricted Stock Unit 48,267 31 Dec 2025 Direct Common Stock
Stock Options 8,969 02 Dec 2025 Direct Common Stock

Transactions reported by Andrew Cittadine for Monopar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.